AIP
INSM icon

Almanack Investment Partners’s Insmed INSM Stock Holding History

Almanack Investment Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,126
Closed -$25K – 659
2022
Q3 		$25K Buy
+1,126
New +$27K ﹤0.01% 345

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Almanack Investment Partners's INSM Position: Q4 2022 in Review

Almanack Investment Partners sold out of Insmed (INSM) in Q4 2022, closing a stake of 1,126 shares — an estimated $25K sold.

Almanack Investment Partners first reported a position in INSM in Q3 2022 and held it in 1 quarter. The position peaked at $25K in Q3 2022. 225 funds tracked by Wall St. Rank hold INSM as of Q4 2022.

  • Almanack Investment Partners reported no remaining Insmed position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,126 Insmed shares in Q4 2022, an estimated $25K.
  • Almanack Investment Partners first reported a position in Insmed in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Insmed position peaked at $25K in Q3 2022.
  • 225 funds tracked by Wall St. Rank held Insmed as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.